Search Result Details

This page shows the details of why an item matched the keywords from your search.
One or more keywords matched the following properties of Flume, Patrick
PropertyValue
keywords Lung
overview Dr. Patrick Flume joined the faculty of the Pulmonary and Critical Care Division at the Medical University of South Carolina in 1993. He is now a Professor of Medicine and Pediatrics, overseeing a rapidly growing Cystic Fibrosis Center. Though he continues to practice general pulmonary and critical care medicine, his primary interests are in CF and bronchiectasis, and chronic lung infections, including nontuberculous mycobacteria. The MUSC Cystic Fibrosis Center is the principal CF program in South Carolina. They provide state-of-the-art care to patients and families with CF; provide primary educator of clinicians and basic scientists in the field of CF; and perform basic and clinical research in the field of CF. Dr. Flume is the MUSC CF Center Director and has national recognition by the national and international CF community having served on the Cystic Fibrosis Foundation Center Committee, the Adult Care Consensus Committee, the Advisory Task Force on Adult Issues, the Professional Education Committee, and as co-chair for the Pulmonary Practice Guidelines Committee. Dr. Flume has an active clinical research program and heads the MUSC Research Nexus.
One or more keywords matched the following items that are connected to Flume, Patrick
Item TypeName
Academic Article Cystic fibrosis: when to consider lung transplantation?
Academic Article Caring for the dying patient with lung cancer.
Academic Article Effect of pulmonary rehabilitation on quality of life in patients with COPD: the use of SF-36 summary scores as outcomes measures.
Academic Article Impact of lung transplantation on site of death in cystic fibrosis.
Academic Article Cystic fibrosis pulmonary guidelines: chronic medications for maintenance of lung health.
Academic Article Update in cystic fibrosis 2009.
Academic Article Cystic fibrosis pulmonary guidelines: pulmonary complications: hemoptysis and pneumothorax.
Academic Article Treatment of lung infection in patients with cystic fibrosis: current and future strategies.
Academic Article Infectious complications of lung transplantation. Impact of cystic fibrosis.
Academic Article Transmissibility of Pseudomonas cepacia infection in clinic patients and lung-transplant recipients with cystic fibrosis.
Academic Article The MUSC lung transplantation program: the first year's experience.
Academic Article The clinical approach to lung disease in patients with cystic fibrosis.
Academic Article Pulmonary exacerbations in cystic fibrosis.
Academic Article Lung transplantation for mechanically ventilated patients.
Academic Article Relief of distress of breathholding: separate effects of expiration and inspiration.
Academic Article Relief of the 'air hunger' of breathholding. A role for pulmonary stretch receptors.
Concept Lung Neoplasms
Concept Lung Diseases
Concept Lung Diseases, Obstructive
Concept Lung Transplantation
Concept Total Lung Capacity
Academic Article Deletion of airway cilia results in noninflammatory bronchiectasis and hyperreactive airways.
Academic Article Lung clearance index. A potential quantitative tool to assess treatment response in bronchiectasis?
Academic Article European Cystic Fibrosis Society Standards of Care: Best Practice guidelines.
Academic Article Probability of IV antibiotic retreatment within thirty days is associated with duration and location of IV antibiotic treatment for pulmonary exacerbation in cystic fibrosis.
Academic Article Short-term and long-term response to pulmonary exacerbation treatment in cystic fibrosis.
Academic Article Intravenous antibiotics for pulmonary exacerbations in people with cystic fibrosis.
Academic Article Early Life Growth Trajectories in Cystic Fibrosis are Associated with Pulmonary Function at Age 6 Years.
Academic Article Forced Expiratory Volume in 1 Second Variability Helps Identify Patients with Cystic Fibrosis at Risk of Greater Loss of Lung Function.
Academic Article Bronchodilators in cystic fibrosis: a critical analysis.
Academic Article Randomized Trial of Liposomal Amikacin for Inhalation in Nontuberculous Mycobacterial Lung Disease.
Academic Article Pulmonary exacerbation in adults with bronchiectasis: a consensus definition for clinical research.
Academic Article Recovery of lung function following a pulmonary exacerbation in patients with cystic fibrosis and the G551D-CFTR mutation treated with ivacaftor.
Academic Article Unmet needs in cystic fibrosis: the next steps in improving outcomes.
Academic Article "Pathogen Eradication" and "Emerging Pathogens": Difficult Definitions in Cystic Fibrosis.
Academic Article Nontuberculous Mycobacteria in Cystic Fibrosis.
Academic Article Amikacin Liposome Inhalation Suspension for Treatment-Refractory Lung Disease Caused by Mycobacterium avium Complex (CONVERT). A Prospective, Open-Label, Randomized Study.
Academic Article Reconciling Antimicrobial Susceptibility Testing and Clinical Response in Antimicrobial Treatment of Chronic Cystic Fibrosis Lung Infections.
Academic Article Pulmonary Complications of Cystic Fibrosis.
Academic Article Amikacin Liposome Inhalation Suspension for Mycobacterium avium Complex Lung Disease: A 12-Month Open-Label Extension Clinical Trial.
Academic Article Amikacin Liposome Inhalation Suspension for Refractory Mycobacterium avium Complex Lung Disease: Sustainability and Durability of Culture Conversion and Safety of Long-term Exposure.
Academic Article Leveraging early markers of cystic fibrosis structural lung disease to improve outcomes.
Academic Article Chest Computed Tomography Features of Nontuberculous Mycobacterial Pulmonary Disease Versus Asymptomatic Colonization: A Cross-sectional Cohort Study.
Academic Article Hospitalization Risk for Medicare Beneficiaries With Nontuberculous Mycobacterial Pulmonary Disease.
Academic Article C-reactive protein (CRP) as a biomarker of pulmonary exacerbation presentation and treatment response.
Academic Article Association of site of treatment with clinical outcomes following intravenous antimicrobial treatment of a pulmonary exacerbation.
Academic Article Health care costs in a randomized trial of antimicrobial duration among cystic fibrosis patients with pulmonary exacerbations.
Academic Article Inhaled nitric oxide for adults with pulmonary non-tuberculous mycobacterial infection.
Search Criteria
  • Lung